Key Events This Week
13 Apr: New 52-week high at Rs.31
15 Apr: Sharp 8.11% price surge on strong volume
16 Apr: Valuation shift to very expensive grade announced
17 Apr: Week closes at Rs.30.66, up 6.83% for the week
May 21
BSE+NSE Vol: 9.64 k

Prism Medico & Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Prism Medico & Pharmacy Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Prism Medico & Pharmacy Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a subtle but meaningful change in price attractiveness. This reclassification comes amid mixed financial metrics and a volatile market backdrop, prompting investors to reassess the stock’s appeal relative to its peers and historical benchmarks.
Read full news article
Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a new 52-week high of Rs 34.49 on 29 Apr 2026, marking a remarkable 128.87% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages.
Read full news article
With a remarkable 131.29% gain over the past year, Prism Medico & Pharmacy Ltd surged to a fresh 52-week high of Rs 34 on 27 Apr 2026, outpacing the Sensex which declined by 2.48% during the same period. This milestone caps a four-day winning streak that has propelled the stock up by 9.47%, underscoring a strong momentum that is supported by a confluence of technical indicators.
Read full news article
Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 33.65 on 24 Apr 2026, marking a remarkable 126.56% gain over the past year. This rally stands in stark contrast to the broader market’s decline, with the Sensex down 3.48% over the same period, underscoring the stock’s strong momentum and technical resilience.
Read full news article
With a decisive break above its previous peak, Prism Medico & Pharmacy Ltd surged to a new 52-week high of Rs 33.58 on 21 Apr 2026, marking a remarkable 107.4% gain over the past year. This milestone comes amid a sustained rally supported by a confluence of bullish technical indicators and a broader market environment that has been steadily advancing.
Read full news article
Surging past its previous peak, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 32.15 on 20 Apr 2026, marking a remarkable doubling in price from its low of Rs 12.49 over the past year. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and steady market participation.
Read full news article